CT angiography for safe discharge of patients with possible acute coronary syndromes

Harold I Litt1, Constantine Gatsonis, Brad Snyder

  • 1Department of Radiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA. harold.litt@uphs.upenn.edu

Insights

Coronary computed tomographic angiography (CCTA) safely expedites emergency department discharge for low-to-intermediate-risk acute coronary syndrome patients. This diagnostic imaging strategy avoids unnecessary hospital admissions, improving patient flow and reducing healthcare costs.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Radiology

Background:

  • Emergency departments frequently admit patients with symptoms suggestive of acute coronary syndromes (ACS).
  • A significant proportion of these patients do not have cardiac causes for their symptoms.
  • Coronary computed tomographic angiography (CCTA) shows high accuracy in ruling out coronary artery disease, but its role in safe emergency department discharge is not fully established.

Purpose of the Study:

  • To evaluate the safety and efficacy of a CCTA-based strategy for managing low-to-intermediate-risk patients presenting with possible ACS.
  • To determine if CCTA can facilitate safe and expedited discharge from the emergency department.

Main Methods:

  • A randomized controlled trial involving 1370 low-to-intermediate-risk patients with possible ACS.
  • Patients were assigned in a 2:1 ratio to undergo CCTA or receive traditional care.
  • The primary safety outcome was the absence of myocardial infarction and cardiac death within 30 days in patients with a negative CCTA.

Main Results:

  • In the CCTA group, 908 patients were enrolled; in the traditional care group, 462 patients were enrolled.
  • Among 640 patients with a negative CCTA, there were no instances of myocardial infarction or cardiac death within 30 days.
  • The CCTA group experienced higher emergency department discharge rates (49.6% vs. 22.7%) and shorter lengths of stay (18.0 hours vs. 24.8 hours) compared to the traditional care group.

Conclusions:

  • A CCTA-based strategy enables the safe and rapid discharge of many low-to-intermediate-risk ACS patients from the emergency department.
  • This approach can reduce hospital admissions for patients whose symptoms are ultimately non-cardiac.
  • CCTA is a valuable tool for risk stratification and management in the emergency department setting for suspected ACS.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
619